- Home
- Companies
- Bio Fire Diagnostics
- Products
- BioFire FilmArray - Model GI - ...
BioFire FilmArray - Model GI -Gastrointestinal Panel
With overlapping symptoms, distinguishing possible causes of gastroenteritis can be challenging for any clinician. To further complicate diagnosis, traditional testing methods are slow, labor intensive, and fail to reveal the etiology of a patient’s gastrointestinal symptoms.1 Fortunately, syndromic testing from the BioFire GI Panel eliminates limitations from conventional methods by providing, faster, more accurate, and comprehensive results.
22 TARGETS IN ONE TEST
The BioFire GI Panel tests for 22 of the most commonly associated pathogens related to gastroenteritis—all from one patient sample, one easy to use reagent, and results are available in about one hour.
THE BIOFIRE GI PANEL MENU
Overall 98.5% Sensitivity and 99.2% Specificity9
Sample Type: Stool in Cary Blair
BACTERIA:
- Campylobacter (jejuni, coli, and upsaliensis)
- Clostridium difficile (toxin A/B)
- Plesiomonas shigelloides
- Salmonella
- Yersinia enterocolitica
- Vibrio (parahaemolyticus, vulnificus, and cholerae)
- Vibrio cholerae
DIARRHEAGENIC E. COLI/SHIGELLA:
- Enteroaggregative E. coli (EAEC)
- Enteropathogenic E. coli (EPEC)
- Enterotoxigenic E. coli (ETEC) lt/st
- Shiga-like toxin-producing E. coli (STEC) stx1/stx2
- E. coli O157
- Shigella/Enteroinvasive E. coli (EIEC)
PARASITES:
- Cryptosporidium
- Cyclospora cayetanensis
- Entamoeba histolytica
- Giardia lamblia
The BioFire GI Panel can streamline workflow by providing faster and more comprehensive test results. Compared to traditional diagnostic methods, syndromic testing from the BioFire GI Panel can:
- Reduce the number of laboratory tests on average from 3 to 13
- Potentially reduce the number of send-out tests
- Reduce the average time to result by 84%
Because traditional stool testing methods are slow and lack sensitivity, clinicians often have to make patient management decisions without a laboratory result. Syndromic testing from the BioFire GI Panel offers fast sample-to-answer turnaround and accurate results, which can:
- Reduce antibiotic use9
- Reduce time to antimicrobial therapy6
- Lead to more targeted therapy6
- Reduce downstream procedures such as endoscopies and abdominal imaging9
Guidelines from American College of Gastroenterology and Infectious Disease Society of America:
- Individuals at high risk of spreading disease to others and during known or suspected outbreaks.1
- Individuals presenting with:1,11
- Dysentery
- Diarrhea with fever, severe abdominal cramps, or signs of sepsis
- Moderate to severe disease
- Symptoms lasting more than seven days
- Immunocompromised patients with diarrhea